首页> 美国卫生研究院文献>Hippokratia >Is the underutilization of peritoneal dialysis in relation to hemodialysis as renal replacement therapy justifiable worldwide? Yes or No
【2h】

Is the underutilization of peritoneal dialysis in relation to hemodialysis as renal replacement therapy justifiable worldwide? Yes or No

机译:在世界范围内与血液透析相关的腹膜透析利用不足作为肾脏替代疗法是否合理?是还是不是

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Peritoneal dialysis is the most important home dialysis treatment for end stage renal diseases and needs personal involvement, and support from the family . Peritoneal dialysis presented a number of discouraging technical problems and led to the belief that PD was not an appropriate renal replacement therapy, for patients with end stage renal disease. Despite the improvement of the method its rate remain low (11%) worldwide. The factors affecting the choice of PD are multiple and explain the disparity in the use of peritoneal dialysis in different countries and different parts of the same country. Dialysis costs and reimbursement structures are significant in decisions about the rates and modalities of renal replacement therapy. Late referral and the health care system seems to be very important factors that influence the dialysis modality choice. After the initiation of peritoneal dialysis we can see other factors that influence the survival of the method. The rate of peritonitis and the peritoneum function seems to be important issues.
机译:腹膜透析是终末期肾脏疾病最重要的家庭透析治疗,需要个人的参与和家人的支持。腹膜透析提出了许多令人沮丧的技术问题,并导致人们认为PD对于患有晚期肾病的患者不是一种合适的肾脏替代疗法。尽管该方法有所改进,但在全球范围内其比率仍然较低(11%)。影响PD选择的因素多种多样,可以解释不同国家和同一国家不同地区使用腹膜透析的差异。在决定肾脏替代治疗的速度和方式时,透析费用和报销结构至关重要。延迟转诊和医疗保健系统似乎是影响透析方式选择的非常重要的因素。开始腹膜透析后,我们可以看到其他影响该方法生存的因素。腹膜炎的发生率和腹膜功能似乎是重要的问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号